• 1
    Alzheimer's Disease International. World Alzheimer Report 2010 – The Global Economic Impact of Dementia. London: Alzheimer's Disease International, 2010.
  • 2
    Leicht H, Heinrich S, Heider D et al. Net costs of dementia by disease stage. Acta Psychiatr Scand 2011;124:384395.
  • 3
    Ferri CP, Prince M, Brayne C et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:21122117.
  • 4
    Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006;67:21762185.
  • 5
    Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;19:252265.
  • 6
    Chapman RM, Mapstone M, McCrary JW et al. Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol 2011;33:187199.
  • 7
    Cui Y, Liu B, Luo S et al. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS ONE 2011;6:e21896.
  • 8
    Devanand DP, Liu X, Tabert MH et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 2008;64:871879.
  • 9
    Ewers M, Walsh C, Trojanowski JQ et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 2012;33:12031214.
  • 10
    Furney SJ, Kronenberg D, Simmons A et al. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease - cytokines and MRI measures together predict disease progression. J Alzheimers Dis 2011;26 (Suppl 3):395405.
  • 11
    Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry 2011;68:961969.
  • 12
    Heister D, Brewer JB, Magda S, Blennow K, Mcevoy LK. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 2011;77:16191628.
  • 13
    Kantarci K, Weigand SD, Przybelski SA et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 2009;72:15191525.
  • 14
    Landau SM, Harvey D, Madison CM et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010;75:230238.
  • 15
    Zaudig M, Hiller W. SIDAM - A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct (or vascular) dementia and dementias of other aetiology according to DSM-III-R, DSM-IV and ICD-10 (SIDAM-manual) [in German]. Bern: Huber, 1996.
  • 16
    Zaudig M, Mittelhammer J, Hiller W et al. SIDAM - A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 1991;21:225236.
  • 17
    Folstein MF, Folstein ME, McHugh PR. Mini-Mental-State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189198.
  • 18
    Hötte SD, Lankers D, Kissler S, Freyberger HJ, Schröder SG. MMSE for survival prognostics in dementia [in German]. Psychiatr Prax 2010;37:7883.
  • 19
    Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179186.
  • 20
    Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. In: Brink TL, ed. Clinical gerontology: a guide to assessment and intervention. New York: Haworth, 1986:165173.
  • 21
    Gauggel S, Birkner B. Validity and reliability of a German version of the Geriatric Depression Scale (GDS) [in German]. Z Klin Psychol 1999;28:1827.
  • 22
    World Health Organization – Regional Office Europe for Europe. Alcohol and health – Implications for Public Health Policy. Report of a WHO Working Group, Oslo, 1995, October.
  • 23
    Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:11361139.
  • 24
    Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797811.
  • 25
    APA – American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders – DSM-IV-TR, 4th edn (Text Revision). Washington, DC: American Psychiatric Association, 2000.
  • 26
    Luck T, Zaudig M, Wiese B, Riedel-Heller SG. SIDAM: age- and education-specific reference values for the cognitive test section according to the new CASMIN educational classification [in German]. Z Gerontopsych Gerontopsychiat 2007;20:3138.
  • 27
    Winblad B, Palmer K, Kivipelto M et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240246.
  • 28
    Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545548.
  • 29
    Van Den Kommer TN, Bontempo DE, Comijs HC et al. Classification models for early identification of persons at risk for dementia in primary care: an evaluation in a sample aged 80 years and older. Dement Geriatr Cogn Disord 2009;28:567577.
  • 30
    Maioli F, Coveri M, Pagni P et al. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr 2007;44(Suppl 1):233241.
  • 31
    Pozueta A, Rodríguez-Rodríguez E, Vaqquez-Higuera JL et al. Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurol 2011;11:78.
  • 32
    Pérès K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurolog 2006;67:461466.
  • 33
    Luck T, Luppa M, Angermeyer MC, Villringer A, König HH, Riedel-Heller SG. Impact of Impairment in Instrumental Activities of Daily Living and Mild Cognitive Impairment on Time to Incident Dementia – Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Psychol Med 2011;41:10871097.
  • 34
    Tabert MH, Albert SM, Borukhova-Milov L et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758764.
  • 35
    Jessen F, Wiese B, Bachmann C et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 2010;67:414422.
  • 36
    Albert MS, Dekosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270279.
  • 37
    Panza F, Frisardi V, Capurso C et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 2010;18:98116.
  • 38
    Shahnawaz Z, Reppermund S, Brodaty H et al. Prevalence and characteristics of depression in mild cognitive impairment: the Sydney Memory and Ageing Study. Acta Psychiatr Scand 2013;127:394402.
  • 39
    Linden M, Gilberg R, Horgas AL, Steinhagen-Thiessen E. Die Inanspruchnahme medizinischer und pflegerischer Hilfe im hohen Alter [in German]. In: Baltes PB, Mayer KU, eds. Die Berliner Altersstudie. Berlin: Akademie Verlag, 1996:475495.
  • 40
    Lauter H, Meyer JE. Clinical and nosological concepts of senile dementia. In: Müller C, Ciompi L, ed. Senile dementia. Bern: Hans Huber, 1968:1326.